| Dr Sheryl L Vaske, RPH PHARMD | |
|
701 W Broad Ave, Flandreau, SD 57028-1529 | |
| (605) 997-2642 | |
| (605) 997-9940 |
| Full Name | Dr Sheryl L Vaske |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 701 W Broad Ave, Flandreau, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457377970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 4501 (South Dakota) | Primary |
| 183500000X | Pharmacist | 114703-0 (Minnesota) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sheryl L Vaske, RPH PHARMD Po Box 326, Elkton, SD 57026-0326 Ph: () - | Dr Sheryl L Vaske, RPH PHARMD 701 W Broad Ave, Flandreau, SD 57028-1529 Ph: (605) 997-2642 |
News Archive
BG Medicine, Inc. announced today that it has entered into an agreement with Siemens Healthcare Diagnostics Inc., a division of Siemens Healthcare, one of the world's largest suppliers of clinical diagnostics to the healthcare industry, for the development and commercialization of a galectin-3 test for Siemens' automated immunoassay platforms for clinical laboratories.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, will be presenting data from the NeuVax Phase II adjuvant breast cancer clinical trial at the 2011 annual meeting of The American Society of Clinical Oncology in Chicago.
Tamro Group's net sales in February-April 2010 amounted to EUR 1,424 million, an increase of 7.4%. A significant part of the sales increase is due to strengthened exchange rates of the Swedish, Norwegian and Polish currencies. At constant exchange rates, Tamro's net sales increased by 1.8%.
A new study, led by professors at the University of Chicago and Duke University, found that COVID-19 cases in the southern state of Karnataka, India, are nearly 95 times greater than reported.
Debiopharm Group (Debiopharm) and Spinomix SA, a Swiss company advancing molecular diagnostic technologies, announced the closing of a Series A equity investment of $ 3 Million.
› Verified 3 days ago
Gina Teresa Johanson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 403 W Broad Ave, Flandreau, SD 57028 Phone: 605-997-2642 Fax: 605-997-2586 | |
Dr. John Daniel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 214 N Prairie St, Flandreau, SD 57028 Phone: 605-997-2433 | |
Mrs. Roxanne Savaryn-wicks, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 127 E 2nd Ave, Flandreau, SD 57028 Phone: 605-997-2122 Fax: 605-997-5408 | |
Ms. Jeanie Alyson Nold, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 127 E 2nd Ave, Flandreau, SD 57028 Phone: 605-997-2122 Fax: 605-997-5408 |